Principles of the Belmont Report and Drug Development
55 Questions
100 Views

Principles of the Belmont Report and Drug Development

Created by
@DivineCopper

Questions and Answers

Which of the following are the three principles included in the Belmont Report?

  • Justice (correct)
  • Respect for Persons (correct)
  • Beneficence (correct)
  • Confidentiality
  • What is an example of how the Principle of Beneficence can be applied to a study employing human subjects?

    Determining that the study has maximized benefits and minimized risks.

    What best describes the principle of Respect for Persons as described in the Belmont Report?

    Information, comprehension, voluntariness.

    How long does the development of most new drugs from discovery to marketing approval usually take?

    <p>9 years or more</p> Signup and view all the answers

    Which phase best describes the clinical phase of a study where adults with a history of migraines were treated with experimental drug X or placebo?

    <p>Phase III</p> Signup and view all the answers

    Long-term toxicology of an experimental drug in animals most likely refers to which part of drug development?

    <p>Preclinical</p> Signup and view all the answers

    Which clinical phase of a study in humans refers to pharmacokinetics and pharmacodynamics of a new formulation of an investigational drug?

    <p>Phase I</p> Signup and view all the answers

    In a phase I new drug study in humans, what is the primary source of data included in the initial Investigator's Brochure?

    <p>Preclinical data</p> Signup and view all the answers

    What is a primary purpose of the ICH?

    <p>Minimize the need for redundant research</p> Signup and view all the answers

    What do the ICH GCP Guidelines set standards for?

    <p>The design, conduct, monitoring, and reporting of clinical research.</p> Signup and view all the answers

    To whom do the ICH E6 GCP describe standards that apply?

    <p>Investigators, sponsors, and IRBs.</p> Signup and view all the answers

    Is following the ICH E6 GCP voluntary in the United States for FDA-regulated drug studies?

    <p>Yes</p> Signup and view all the answers

    Regarding explaining the probability of assignment to trial arms in consent forms, what does the ICH note?

    <p>It should be included, but does not specify how the information should be presented.</p> Signup and view all the answers

    What do FDA regulations state about the subject's receipt of consent forms?

    <p>Subjects may receive either a signed or unsigned copy.</p> Signup and view all the answers

    What is required by the new ICH E6 integrated addendum (R2) regarding the management of quality in trials?

    <p>Identification of study risks to determine which may safely be omitted from continual monitoring.</p> Signup and view all the answers

    What must investigators disclose in the informed consent form when complying with ICH E6 guidelines?

    <p>That the monitor, auditor, IRB/IEC, and regulatory authorities may have access to the subject's medical records.</p> Signup and view all the answers

    What is the legal status of ICH in the U.S.?

    <p>It is a FDA guidance.</p> Signup and view all the answers

    What is an acceptable criterion for determining that a study of an approved drug does not require an IND?

    <p>The study is not intended to be reported to FDA to support a new indication or labeling change.</p> Signup and view all the answers

    What must a sponsor-investigator holding an IND be responsible for annually reporting to the FDA?

    <p>IND report</p> Signup and view all the answers

    Who is responsible for making the initial risk determination for a device being used in a study?

    <p>The sponsor-investigator</p> Signup and view all the answers

    When must the investigator update the IRB about the progress of a trial?

    <p>During the conduct of the study and at termination.</p> Signup and view all the answers

    Who is responsible for reporting directly to the FDA the investigator's financial interests with the sponsor?

    <p>The sponsor</p> Signup and view all the answers

    What is an investigator's commitment to the sponsor?

    <p>Submit a new Form FDA 1572 to sponsor as needed.</p> Signup and view all the answers

    To whom must the investigator report adverse events?

    <p>Sponsor</p> Signup and view all the answers

    What is Form FDA 1572, Statement of Investigator?

    <p>Legally binding between the Investigator and the FDA.</p> Signup and view all the answers

    What is an important component of drug accountability?

    <p>Drug shipping and disposition records.</p> Signup and view all the answers

    Who has ultimate responsibility for an investigational product?

    <p>Investigator</p> Signup and view all the answers

    Where is investigational product dispensing or administration information recorded for the sponsor?

    <p>Case report form</p> Signup and view all the answers

    What should the packaging of investigational drugs ideally do?

    <p>Help with subject compliance.</p> Signup and view all the answers

    Where is information on storage requirements for the investigational product usually found?

    <p>In the study protocol</p> Signup and view all the answers

    What must an investigator conducting a study of a medical device under an IDE complete and sign?

    <p>An investigator's agreement.</p> Signup and view all the answers

    When is a 510(k) Premarket Notification submitted?

    <p>When the new device to be marketed is substantially similar (equivalent) to one already on the market.</p> Signup and view all the answers

    Who must report Evaluation of Unanticipated Adverse Device Effects (UADEs) to the FDA?

    <p>Sponsor</p> Signup and view all the answers

    What should an investigator do if a subject enrolled in a phase III study has access to a new beneficial drug?

    <p>Discuss the pros and cons of both drugs and allow the subject to decide.</p> Signup and view all the answers

    What describes the best course of action for an investigator using a test article in a life-threatening situation without consent?

    <p>The investigator and another physician agree on the necessity to use the test article and will notify the IRB later.</p> Signup and view all the answers

    Which statement in a consent form is an example of exculpatory language?

    <p>I waive any possibility of compensation for injuries that I may receive as a result of participation in this research.</p> Signup and view all the answers

    Under which circumstance does the FDA allow verbal consent prior to participation in a research study?

    <p>The study is minimal risk.</p> Signup and view all the answers

    When evaluating the causality of an adverse event, what should be considered?

    <p>The timing of the event in relation to administration of the investigational agent.</p> Signup and view all the answers

    Why is accurate reporting of adverse events most important?

    <p>Ensuring subject safety.</p> Signup and view all the answers

    What should an investigator do when learning of a subject involved in a car crash sustaining injuries?

    <p>Report adverse events of both a broken wrist and a mild concussion.</p> Signup and view all the answers

    Who should determine causality of a serious adverse event in a subject enrolled in a phase I study?

    <p>Principal Investigator</p> Signup and view all the answers

    Under what conditions must a sponsor submit an IND safety report to the FDA?

    <p>If an adverse event is serious, unexpected, and there is a reasonable possibility that the drug caused the event.</p> Signup and view all the answers

    In a double-blinded trial, what should the investigator submit an SAE report for?

    <p>Both of the subjects.</p> Signup and view all the answers

    For which observations is an IND Safety Report most likely to be filed with the FDA?

    <p>Subject 603 only</p> Signup and view all the answers

    What should an investigator do if a subject has elevated WBC counts without clinical signs?

    <p>Report the elevated WBC to the sponsor as an unexpected adverse effect.</p> Signup and view all the answers

    How is an 'Audit' defined according to ICH E6 GCP?

    <p>A systematic and independent examination of trial-related activities and documents.</p> Signup and view all the answers

    How is an inspection defined according to ICH E6 GCP?

    <p>An official review of documents, facilities, records, and any other resources related to a clinical trial.</p> Signup and view all the answers

    What will FDA inspectors do during an inspection?

    <p>Review regulatory records.</p> Signup and view all the answers

    What is the overall goal of monitoring, audits, and inspection activities?

    <p>Ensure the protection of human research subjects and data integrity.</p> Signup and view all the answers

    What is OHRP primarily concerned with?

    <p>Protection of human research subjects.</p> Signup and view all the answers

    When should the sponsor-monitor conduct the most detailed review of the study protocol with the site's study staff?

    <p>Site initiation visit</p> Signup and view all the answers

    When is the majority of case report form (CRF) data verified against source record information?

    <p>Periodic site visits</p> Signup and view all the answers

    At which study visits can the sponsor expect to review subjects' signed informed consent forms?

    <p>Periodic and termination site visits</p> Signup and view all the answers

    Which is required at a prestudy site visit?

    <p>Evaluation of the site's capacity to conduct the study.</p> Signup and view all the answers

    Which monitoring visit would NOT include an inventory of investigational agents?

    <p>Prestudy site visit</p> Signup and view all the answers

    Study Notes

    Principles of the Belmont Report

    • Key principles: Respect for Persons, Beneficence, Justice.
    • Respect for Persons entails information, comprehension, and voluntariness in informed consent.

    Application of Beneficence

    • Beneficence in studies involves maximizing benefits while minimizing risks to participants.

    Drug Development Timeline

    • Development of new drugs typically requires 9 years or more from discovery to market approval.

    Clinical Study Phases

    • Randomized studies of interventions like drug X on migraine patients classify as Phase III trials.
    • Phase I studies focus on pharmacokinetics and pharmacodynamics of new formulations.
    • Preclinical studies evaluate long-term drug toxicity in animals.

    ICH and GCP Guidelines

    • The ICH aims to minimize redundant research and establish standards for clinical trials.
    • ICH GCP guidelines specify responsibilities for investigators, sponsors, and IRBs.

    Compliance and Regulatory Aspects

    • Following ICH E6 GCP in the U.S. is voluntary for FDA-regulated drug studies.
    • Consent forms must clarify probability of assignment to trial arms, without mandated formats.
    • Subjects can receive either signed or unsigned copies of consent forms.

    Risk Management and Quality Systems

    • ICH E6 requires sponsors to implement risk-based quality management throughout trial stages, identifying study risks appropriately.
    • ICH E6 has stringent requirements for confidentiality regarding medical records and subject access.

    Investigator Responsibilities

    • The sponsor-investigator is responsible for making initial risk determinations for devices in studies and reporting annually to the FDA.
    • Investigators must update IRBs about trial progress and submit Form FDA 1572 when necessary.

    Adverse Event Reporting

    • Adverse events must be reported to the sponsor, and accurate reporting is critical for subject safety.
    • Causality evaluations of adverse events consider the timing of the event relative to drug administration.
    • Serious unexpected adverse events must prompt IND safety reports to the FDA if reasonably believed to be caused by the drug.

    Monitoring and Auditing

    • Audits are independent examinations of trial-related activities, while inspections involve official reviews by regulators.
    • The primary goal of monitoring and audits is to protect human research subjects and ensure data integrity.

    Special Situations

    • In life-threatening situations necessitating rapid action, the investigator can use a test article without prior consent but must notify the IRB later.
    • Discussing alternative treatment options with subjects enrolled in ongoing trials is essential when new beneficial therapies arise.

    Study Logistics

    • Investigator must report elevated lab values, even if not listed as adverse events, to the sponsor.
    • Inventory checks for investigational products occur during periodic site visits but not during pre-study visits.

    Oversight and Ethical Standards

    • OHRP focuses on the protection of human research subjects ensuring ethical standards in clinical trials.
    • The site initiation visit is critical for thorough reviews of the protocol and site staff capabilities.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the key principles outlined in the Belmont Report, including respect for persons, beneficence, and justice. It also explores the drug development timeline, phases of clinical studies, and the importance of ICH and GCP guidelines for compliance in clinical trials.

    More Quizzes Like This

    Research Ethics and Belmont Principles
    12 questions
    CITI Training: Belmont Report Principles
    85 questions
    Belmont Report Principles Flashcards
    6 questions
    Use Quizgecko on...
    Browser
    Browser